Neurofilament accumulation disrupts autophagy in giant axonal neuropathy

被引:0
|
作者
Paumier, Jean-Michel [1 ]
Zewe, James [1 ]
Panja, Chiranjit [1 ]
Pergande, Melissa R. [1 ,4 ]
Venkatesan, Meghana [1 ]
Israeli, Eitan [1 ,5 ]
Prasad, Shikha [1 ]
Snider, Natasha [2 ]
Savas, Jeffrey N. [1 ]
Opal, Puneet [1 ,3 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL USA
[2] Univ North Carolina Chapel Hill, Sch Med, Dept Cell Biol & Physiol, Chapel Hill, NC USA
[3] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL USA
[4] Boston Univ, Dept Chem, Boston, MA USA
[5] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Sch, Barry Skolnick Biosafety Level Unit 3, Jerusalem, Israel
关键词
PROTEIN; GIGAXONIN; MATURATION; CLEARANCE; LYSOSOMES; FAMILY;
D O I
10.1172/jci.insight.177999
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Neurofilament accumulation is associated with many neurodegenerative diseases, but it is the primary pathology in giant axonal neuropathy (GAN). This childhood-onset autosomal recessive disease is caused by loss-of-function mutations in gigaxonin, the E3 adaptor protein that enables neurofilament degradation. Using a combination of genetic and RNA interference approaches, we found that dorsal root ganglia from mice lacking gigaxonin have impaired autophagy and lysosomal degradation through 2 mechanisms. First, neurofilament accumulations interfere with the distribution of autophagic organelles, impairing their maturation and fusion with lysosomes. Second, the accumulations attract the chaperone 14-3-3, which is responsible for the proper localization of the key autophagy regulator transcription factor EB (TFEB). We propose that this dual disruption of autophagy contributes to the pathogenesis of other neurodegenerative diseases involving neurofilament accumulations.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] GIANT AXONAL NEUROPATHY - ACCELERATION OF NEUROFILAMENT TRANSPORT IN OPTIC AXONS
    MONACO, S
    AUTILIOGAMBETTI, L
    ZABEL, D
    GAMBETTI, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) : 920 - 924
  • [2] Serum neurofilament light chain analysis in giant axonal neuropathy
    Bharucha-Goebel, D.
    Saade, D.
    Paredes, E.
    Hu, Y.
    Saxena, A.
    Mccoy, P.
    Averion, G.
    Jain, M.
    Norato, G.
    Cheung, K.
    Waite, M.
    Foley, R.
    Lehky, T.
    Gray, S.
    Bonnemann, C.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S149 - S149
  • [3] Explaining intermediate filament accumulation in giant axonal neuropathy
    Opal, Puneet
    Goldman, Robert D.
    RARE DISEASES, 2013, 1 (01)
  • [4] Giant axonal neuropathy
    Crete, Ryan
    Jorgensen, Scott A.
    Towbin, Alexander J.
    Towbin, Richard
    APPLIED RADIOLOGY, 2018, 47 (05) : 40 - 41
  • [5] GIANT AXONAL NEUROPATHY
    LAMPL, Y
    ESHEL, Y
    GILAD, R
    SAROVAPINHAS, I
    NEUROLOGY, 1993, 43 (10) : 2156 - 2156
  • [6] Giant axonal neuropathy
    Sharkey, Emma
    Griffiths, Sian E. M.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2020, 61 : S273 - S280
  • [7] Giant axonal neuropathy
    Gordon, N
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2004, 46 (10): : 717 - 719
  • [8] Giant axonal neuropathy
    Yang, Y.
    Allen, E.
    Ding, J.
    Wang, W.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (05) : 601 - 609
  • [9] GIANT AXONAL NEUROPATHY
    ASBURY, AK
    BERG, BO
    GALE, MK
    COX, SC
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1972, 31 (01): : 196 - &
  • [10] Giant Axonal Neuropathy
    Vijaykumar, Kadambari
    Bindu, Parayil Sankaran
    Taly, Arun B.
    Mahadevan, Anita
    Bharath, Rose Dawn
    Gayathri, Narayanappa
    Nagappa, Madhu
    Sinha, Sanjib
    JOURNAL OF CHILD NEUROLOGY, 2015, 30 (07) : 912 - 915